However, Gartner and colleagues found elevated PTK7 mRNA expression level in TNBC cell lines and PTK7 overexpression in metastatic lymph node predicts shorter disease-free survival (DFS) in breast cancer patients (24). This evidence concerns the gene PTK7 and breast carcinoma.